Grafa News and Videos — Page 316

707 Cayman Holdings (NASDAQ:JEM) announced it will not proceed with its previously proposed acquisition of Crucial Innovation following a board review.

Immersion Corporation (NASDAQ:IMMR) reported total revenues of $294.4 million for the first quarter of fiscal 2027, reversing a prior-year net loss.

Amgen (NASDAQ:AMGN) received U.S. FDA approval to update the prescribing information for IMDELLTRA, reducing the initial monitoring time to 6–8 hours.

Boeing (NYSE:BA) and American Airlines (NASDAQ:AAL) completed the first 737 MAX landing gear exchange on September 14, 2026.

Canaan (NASDAQ:CAN) released its August 2026 update, mining 44 Bitcoin and securing US$13.9 million from asset sales.

Pasithea Therapeutics (NASDAQ:KTTA) announced that it will present initial clinical data from Part A of its ongoing Phase 1/1b trial evaluating PAS-004 in adults with neurofibromatosis type 1 (NF1).

RF Industries (NASDAQ:RFIL) reported record third-quarter fiscal 2026 net sales of $23.96 million, representing a 21% year-over-year increase.

Corbus Pharmaceuticals (NASDAQ:CRBP) reported Phase 1b data showing a 5% mean weight loss with CRB-913 after 12 weeks.

Definium Therapeutics (NASDAQ:DFTX) reported positive topline results from the Phase 3 Panorama study evaluating DT120 (lysergide) Orally Disintegrating Tablet in adults with generalized anxiety disorder.

Phio Pharmaceuticals (NASDAQ:PHIO) submitted a meeting request and comprehensive briefing package to the U.S. Food and Drug Administration to support the next phase of development for its INTASYL siRNA candidate PH-762.